Myriad Genetics sell JPMorgan Chase & Co.
Start price
07.08.24
/
50%
€23.80
Target price
07.08.25
€18.31
Performance (%)
-78.57%
End price
08.08.25
€5.10
Summary
This prediction ended on 08.08.25 with a price of €5.10. The SELL prediction by JPMorgan_Chase___Co_ for Myriad Genetics performed very well with a performance of -78.57%. JPMorgan_Chase___Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Myriad Genetics | 1.731% | 1.731% | 23.425% |
| iShares Core DAX® | -1,09 % | 0,20 % | 2,09 % |
| iShares Nasdaq 100 | -2,46 % | -1,79 % | 29,25 % |
| iShares Nikkei 225® | -5,37 % | -5,43 % | 54,33 % |
| iShares S&P 500 | -0,20 % | 1,77 % | 23,58 % |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread Myriad Genetics diskutieren
Myriad Genetics, Inc. (NASDAQ: MYGN) had its price target raised by analysts at JPMorgan Chase & Co. from $17.00 to $20.00. They now have an "underweight" rating on the stock.
Ratings data for MYGN provided by MarketBeat
In the thread Trading Myriad Genetics
Die von JPMorgan_Chase___Co_ gewählte maximale Laufzeit wurde überschritten